Abstract
Untoward side effects of pharmaceuticals can result in considerable morbidity and expense to the health care system. There is likely a sizable fraction of the hypertensive population with disease either induced or exacerbated by polypharmacy. The elevation of blood pressure in drug-induced hypertension occurs through a variety of mechanisms, most notably, sodium and fluid retention, activation of the renin-angiotensin-aldosterone system, alteration of vascular tone, or a combination of these pathways. Recognition of common medications causing drug-induced hypertension is important to effectively control blood pressure. The epidemiology, pathophysiology, and management of these agents are discussed.
Original language | English (US) |
---|---|
Pages (from-to) | 859-873 |
Number of pages | 15 |
Journal | Endocrinology and metabolism clinics of North America |
Volume | 48 |
Issue number | 4 |
DOIs | |
State | Published - Dec 2019 |
Keywords
- Drug-induced hypertension
- Polypharmacy
- Secondary hypertension
ASJC Scopus subject areas
- Endocrinology, Diabetes and Metabolism
- Endocrinology